Connecticut 2019 2019 Regular Session

Connecticut House Bill HB07261 Comm Sub / Bill

Filed 04/17/2019

                     
 
LCO 4615  \\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07261-R02-
HB.docx  
1 of 2 
  
General Assembly  Raised Bill No. 7261  
January Session, 2019  
LCO No. 4615 
 
 
Referred to Committee on INSURANCE AND REAL 
ESTATE  
 
 
Introduced by:  
(INS)  
 
 
 
AN ACT PROHIBITING REQUIREMENTS FOR PRES CRIBING 
CLINICALLY INAPPROPR IATE QUANTITIES OF OUTPATIENT 
PSYCHOTROPIC DRUGS.  
Be it enacted by the Senate and House of Representatives in General 
Assembly convened: 
 
Section 1. (NEW) (Effective January 1, 2020) Notwithstanding any 1 
provision of the general statutes, no individual health insurance policy 2 
providing coverage of the type specified in subdivisions (1), (2), (4), 3 
(11), (12) and (16) of section 38a-469 of the general statutes delivered, 4 
issued for delivery, renewed, amended or continued in this state on or 5 
after January 1, 2020, that provides coverage for outpatient 6 
prescription drugs shall require a prescribing health care provider to 7 
prescribe an outpatient psychotropic drug in a quantity that such 8 
provider deems clinically inappropriate. 9 
Sec. 2. (NEW) (Effective January 1, 2020) Notwithstanding any 10 
provision of the general statutes, no group health insurance policy 11 
providing coverage of the type specified in subdivisions (1), (2), (4), 12 
(11), (12) and (16) of section 38a-469 of the general statutes delivered, 13 
issued for delivery, renewed, amended or continued in this state on or 14  Raised Bill No. 7261 
 
 
LCO 4615  {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07261-
R02-HB.docx }   
2 of 2 
 
after January 1, 2020, that provides coverage for outpatient 15 
prescription drugs shall require a prescribing health care provider to 16 
prescribe an outpatient psychotropic drug in a quantity that such 17 
provider deems clinically inappropriate. 18 
Sec. 3. Section 38a-476b of the general statutes is repealed and the 19 
following is substituted in lieu thereof (Effective January 1, 2020): 20 
Notwithstanding any provision of the general statutes or the 21 
regulations of Connecticut state agencies, no mental health care benefit 22 
provided under state law, or with state funds or to state employees 23 
may, through the use of a drug formulary, list of covered drugs or any 24 
other means: (1) Limit the availability of psychotropic drugs that are 25 
the most effective therapeutically indicated pharmaceutical treatment 26 
with the least probability of adverse side effects; [or] (2) require 27 
utilization of psychotropic drugs that are not the most effective 28 
therapeutically indicated pharmaceutical treatment with the least 29 
probability of adverse side effects; or (3) require a prescribing health 30 
care provider to prescribe an outpatient psychotropic drug in a 31 
quantity that such provider deems clinically inappropriate. Nothing in 32 
this section shall be construed to limit the authority of a physician to 33 
prescribe a drug that is not the most recent pharmaceutical treatment. 34 
Nothing in this section shall be construed to prohibit differential 35 
copays among pharmaceutical treatments or to prohibit utilization 36 
review.  37 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 January 1, 2020 New section 
Sec. 2 January 1, 2020 New section 
Sec. 3 January 1, 2020 38a-476b 
 
INS Joint Favorable  
PH Joint Favorable